According to a recent LinkedIn post from Latent, the company is highlighting efficiency gains achieved in an appeal workflow partnership with Ochsner Health. The post suggests that average time to draft each appeal letter has been reduced from an estimated 45–60 minutes to about 5–7 minutes.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
As described in the post, this time reduction is framed as enabling faster turnaround for patients, more consistent workflows, and allowing pharmacy teams to reallocate time to direct care. The post also cites roughly 80 hours saved per month on appeal drafting, implying potential labor cost savings and higher operational throughput for healthcare partners.
From an investor perspective, these reported productivity gains may signal growing proof points for Latent’s value proposition in healthcare administrative workflows. Demonstrated time savings in collaboration with a recognized health system like Ochsner could support customer acquisition efforts and pricing power, potentially improving revenue prospects if such results are scalable.
The collaboration also underscores Latent’s focus on pharmacy-related processes, hinting at a niche where workflow automation and clinical operations intersect. If the company can replicate similar outcomes across additional health systems, it may strengthen its competitive position in the healthcare technology and revenue-cycle support market.